JAHA:先天性心脏病术后康复治疗的预测因子

2018-05-13 xiangting MedSci原创

近一半接受先天性心脏病手术的患者在术后进行康复治疗。康复治疗的使用频率和治疗类型根据患者特征而有所不同;然而,某些术前和术中因素与康复治疗的需要相关。

先天性心脏病患者在心脏手术后存在运动、认知、言语和喂养困难的风险。如果在术后住院期间早期开始康复治疗,可以改善该人群的功能结局。然而,关于儿童术后早期康复治疗需求类型的信息很少。这项研究的目标是描述先天性心脏手术后的康复疗法以及与治疗需求相关的术前/术中因素。

这是一项回顾性队列研究,纳入2013年1月1日至2015年1月31日在作者所在中心接受心脏手术的18岁以下患者。收集人口学以及术前、术中、术后的临床和康复治疗(身体,职业,言语,喂养疗法和神经发育干预)数据。术后早期的康复治疗需求,尤其是姑息修复后,是多因素logistic回归模型中识别和治疗相关的独立术前和术中因素的结局变量。1415名受试者中共有586人(41%)术后接受了康复治疗。某些亚组的康复治疗比例高,如新生儿(80%)。在多因素分析中,姑息性修复、早产、遗传性综合征、术前住院时间超过1天和体外循环时间延长均与康复治疗独立相关。

近一半接受先天性心脏病手术的患者在术后进行康复治疗。康复治疗的使用频率和治疗类型根据患者特征而有所不同;然而,某些术前和术中因素与康复治疗的需要相关,并有助于决策制定以适当的分配资源。

原始出处:

本文系梅斯医学(MedSci)原创编译整理,转载需授权!

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1676982, encodeId=fe6f16e698298, content=<a href='/topic/show?id=9fd161052bc' target=_blank style='color:#2F92EE;'>#术后康复#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61052, encryptionId=9fd161052bc, topicName=术后康复)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=480b27414313, createdName=wwzzly, createdTime=Mon Jan 28 11:48:00 CST 2019, time=2019-01-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1267815, encodeId=33dd126e81563, content=<a href='/topic/show?id=922f21183d' target=_blank style='color:#2F92EE;'>#AHA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2118, encryptionId=922f21183d, topicName=AHA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e886, createdName=仁者大医, createdTime=Tue May 15 05:48:00 CST 2018, time=2018-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1310679, encodeId=f2e213106e903, content=<a href='/topic/show?id=25dc1002255e' target=_blank style='color:#2F92EE;'>#预测因子#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100225, encryptionId=25dc1002255e, topicName=预测因子)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6105386, createdName=宋威, createdTime=Tue May 15 05:48:00 CST 2018, time=2018-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1369368, encodeId=3523136936895, content=<a href='/topic/show?id=bc9f28589d0' target=_blank style='color:#2F92EE;'>#先天性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28589, encryptionId=bc9f28589d0, topicName=先天性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a435298, createdName=huirong, createdTime=Tue May 15 05:48:00 CST 2018, time=2018-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=314771, encodeId=87eb314e719b, content=学习了.谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220115/46bcf39c32de4aa6b45c5f9d66c8ee77/6cb4a20c55bb4b7691122f47747bfca2.jpg, createdBy=9dad1662329, createdName=1ddf0692m34(暂无匿称), createdTime=Sun May 13 16:42:52 CST 2018, time=2018-05-13, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1676982, encodeId=fe6f16e698298, content=<a href='/topic/show?id=9fd161052bc' target=_blank style='color:#2F92EE;'>#术后康复#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61052, encryptionId=9fd161052bc, topicName=术后康复)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=480b27414313, createdName=wwzzly, createdTime=Mon Jan 28 11:48:00 CST 2019, time=2019-01-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1267815, encodeId=33dd126e81563, content=<a href='/topic/show?id=922f21183d' target=_blank style='color:#2F92EE;'>#AHA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2118, encryptionId=922f21183d, topicName=AHA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e886, createdName=仁者大医, createdTime=Tue May 15 05:48:00 CST 2018, time=2018-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1310679, encodeId=f2e213106e903, content=<a href='/topic/show?id=25dc1002255e' target=_blank style='color:#2F92EE;'>#预测因子#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100225, encryptionId=25dc1002255e, topicName=预测因子)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6105386, createdName=宋威, createdTime=Tue May 15 05:48:00 CST 2018, time=2018-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1369368, encodeId=3523136936895, content=<a href='/topic/show?id=bc9f28589d0' target=_blank style='color:#2F92EE;'>#先天性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28589, encryptionId=bc9f28589d0, topicName=先天性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a435298, createdName=huirong, createdTime=Tue May 15 05:48:00 CST 2018, time=2018-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=314771, encodeId=87eb314e719b, content=学习了.谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220115/46bcf39c32de4aa6b45c5f9d66c8ee77/6cb4a20c55bb4b7691122f47747bfca2.jpg, createdBy=9dad1662329, createdName=1ddf0692m34(暂无匿称), createdTime=Sun May 13 16:42:52 CST 2018, time=2018-05-13, status=1, ipAttribution=)]
    2018-05-15 仁者大医
  3. [GetPortalCommentsPageByObjectIdResponse(id=1676982, encodeId=fe6f16e698298, content=<a href='/topic/show?id=9fd161052bc' target=_blank style='color:#2F92EE;'>#术后康复#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61052, encryptionId=9fd161052bc, topicName=术后康复)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=480b27414313, createdName=wwzzly, createdTime=Mon Jan 28 11:48:00 CST 2019, time=2019-01-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1267815, encodeId=33dd126e81563, content=<a href='/topic/show?id=922f21183d' target=_blank style='color:#2F92EE;'>#AHA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2118, encryptionId=922f21183d, topicName=AHA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e886, createdName=仁者大医, createdTime=Tue May 15 05:48:00 CST 2018, time=2018-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1310679, encodeId=f2e213106e903, content=<a href='/topic/show?id=25dc1002255e' target=_blank style='color:#2F92EE;'>#预测因子#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100225, encryptionId=25dc1002255e, topicName=预测因子)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6105386, createdName=宋威, createdTime=Tue May 15 05:48:00 CST 2018, time=2018-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1369368, encodeId=3523136936895, content=<a href='/topic/show?id=bc9f28589d0' target=_blank style='color:#2F92EE;'>#先天性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28589, encryptionId=bc9f28589d0, topicName=先天性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a435298, createdName=huirong, createdTime=Tue May 15 05:48:00 CST 2018, time=2018-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=314771, encodeId=87eb314e719b, content=学习了.谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220115/46bcf39c32de4aa6b45c5f9d66c8ee77/6cb4a20c55bb4b7691122f47747bfca2.jpg, createdBy=9dad1662329, createdName=1ddf0692m34(暂无匿称), createdTime=Sun May 13 16:42:52 CST 2018, time=2018-05-13, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1676982, encodeId=fe6f16e698298, content=<a href='/topic/show?id=9fd161052bc' target=_blank style='color:#2F92EE;'>#术后康复#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61052, encryptionId=9fd161052bc, topicName=术后康复)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=480b27414313, createdName=wwzzly, createdTime=Mon Jan 28 11:48:00 CST 2019, time=2019-01-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1267815, encodeId=33dd126e81563, content=<a href='/topic/show?id=922f21183d' target=_blank style='color:#2F92EE;'>#AHA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2118, encryptionId=922f21183d, topicName=AHA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e886, createdName=仁者大医, createdTime=Tue May 15 05:48:00 CST 2018, time=2018-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1310679, encodeId=f2e213106e903, content=<a href='/topic/show?id=25dc1002255e' target=_blank style='color:#2F92EE;'>#预测因子#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100225, encryptionId=25dc1002255e, topicName=预测因子)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6105386, createdName=宋威, createdTime=Tue May 15 05:48:00 CST 2018, time=2018-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1369368, encodeId=3523136936895, content=<a href='/topic/show?id=bc9f28589d0' target=_blank style='color:#2F92EE;'>#先天性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28589, encryptionId=bc9f28589d0, topicName=先天性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a435298, createdName=huirong, createdTime=Tue May 15 05:48:00 CST 2018, time=2018-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=314771, encodeId=87eb314e719b, content=学习了.谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220115/46bcf39c32de4aa6b45c5f9d66c8ee77/6cb4a20c55bb4b7691122f47747bfca2.jpg, createdBy=9dad1662329, createdName=1ddf0692m34(暂无匿称), createdTime=Sun May 13 16:42:52 CST 2018, time=2018-05-13, status=1, ipAttribution=)]
    2018-05-15 huirong
  5. [GetPortalCommentsPageByObjectIdResponse(id=1676982, encodeId=fe6f16e698298, content=<a href='/topic/show?id=9fd161052bc' target=_blank style='color:#2F92EE;'>#术后康复#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61052, encryptionId=9fd161052bc, topicName=术后康复)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=480b27414313, createdName=wwzzly, createdTime=Mon Jan 28 11:48:00 CST 2019, time=2019-01-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1267815, encodeId=33dd126e81563, content=<a href='/topic/show?id=922f21183d' target=_blank style='color:#2F92EE;'>#AHA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2118, encryptionId=922f21183d, topicName=AHA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e886, createdName=仁者大医, createdTime=Tue May 15 05:48:00 CST 2018, time=2018-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1310679, encodeId=f2e213106e903, content=<a href='/topic/show?id=25dc1002255e' target=_blank style='color:#2F92EE;'>#预测因子#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100225, encryptionId=25dc1002255e, topicName=预测因子)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6105386, createdName=宋威, createdTime=Tue May 15 05:48:00 CST 2018, time=2018-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1369368, encodeId=3523136936895, content=<a href='/topic/show?id=bc9f28589d0' target=_blank style='color:#2F92EE;'>#先天性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28589, encryptionId=bc9f28589d0, topicName=先天性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a435298, createdName=huirong, createdTime=Tue May 15 05:48:00 CST 2018, time=2018-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=314771, encodeId=87eb314e719b, content=学习了.谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220115/46bcf39c32de4aa6b45c5f9d66c8ee77/6cb4a20c55bb4b7691122f47747bfca2.jpg, createdBy=9dad1662329, createdName=1ddf0692m34(暂无匿称), createdTime=Sun May 13 16:42:52 CST 2018, time=2018-05-13, status=1, ipAttribution=)]
    2018-05-13 1ddf0692m34(暂无匿称)

    学习了.谢谢分享

    0

相关资讯

2018 EHRA/AEPC/ESC意见书:先天性心脏病患者心律失常

先天性心脏病患者人群随着越来越多的患者进入成人期二不断增加,这些患者中有很大一部分人由于疾病本身或是经过介入或外科治疗而患有心律失常。本文主要针对该类人群心律失常的诊断和治疗提出指导建议。

JACC:大右室流出道患者进行分支肺动脉瓣植入可以减少肺返流并改善右心室大小/功能

经皮分支PA瓣膜置入术可以减少右心室容积,并在中期有临床获益。

JAHA:先天性心脏病合并肺动脉高压患者的肺功能、炎症及内皮素1水平分析!

由此可见,CHD-APAH患者炎症生物标志物水平升高。呼吸道生理的显著异常可能导致呼吸困难,但不受循环和痰液细胞因子的影响。增加的血清内皮素-1和气道功能障碍之间的关系可能与支气管收缩性能相关。

Heart:对复杂先天性心脏病患儿进行低氧试验的意义!

商用飞机的机舱氧浓度相当于吸入0.15的氧气,这会导致乘客的氧饱和度(SpO2)降低。这种情况对复杂先天性心脏病(CHD)患儿的影响尚不清楚。近期,一项发表在杂志Heart上的研究进行了缺氧挑战测试(HCT)来评估机上补充氧气的需求。此项研究选取了年龄<16岁的儿童且符合标准的HCT。受试者分为(A)正常组与基线SpO2异常组(≥95%vs <95%)以及(B)缺少与存在实际/潜在右向

阜外学者:先天性心脏病相关肺动脉高压在我国常见,多见于中青年女性

阜外医院肺血管病中心学者分析发现,在我国,先天性心脏病相关肺动脉高压是我国最为常见的肺动脉高压类型,且好发于中青年女性,其次为特发性肺动脉高压、结缔组织病相关性肺动脉高压和慢性血栓栓塞性肺动脉高压。

South Med J:先天性心脏病患者中HCV的流行率和直接抗病毒治疗的效果

在1992年之前接受了心脏手术的先天性心脏病成年患者,接受HCV抗体检查,如果抗体检测呈阳性,则可以考虑使用直接作用的抗病毒药物进行治疗,并密切监测心脏并发症